Inspiration Research Limited (IRL) is an independent company founded in 2003 by Dr. Kenneth Chapman. His vision for Inspiration Research is to educate patients to better manage their diseases and contribute to the advancement of novel therapies. Since inception, Inspiration Research has successfully completed over 70 human clinical studies with leading global pharmaceutical and biotechnology companies including GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, Amgen, AstraZeneca, Nycomed, Schering-Plough, and Forest Laboratories.Currently, IRL specializes in clinical studies with patients diagnosed with asthma, heart disease and COPD.
In addition, IRL operates a pulmonary function test laboratory. Pulmonary function tests are valuable tools for doctors to diagnose patients with asthma, COPD, and other respiratory disease.